Milestone Pharmaceuticals, Inc. (MIST)
0.7185
+0.02
(+2.63%)
USD |
NASDAQ |
Oct 20, 16:00
0.7133
-0.01
(-0.72%)
After-Hours: 20:00
Milestone Pharmaceuticals Gross Profit (TTM) : 2.125M for June 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.125M |
| March 31, 2026 | 1.627M |
| December 31, 2025 | 1.432M |
| September 30, 2025 | -0.647M |
| June 30, 2025 | -0.647M |
| March 31, 2025 | -0.645M |
| December 31, 2024 | -0.646M |
| September 30, 2024 | -0.611M |
| June 30, 2024 | -0.61M |
| March 31, 2024 | -0.608M |
| December 31, 2023 | 0.402M |
| September 30, 2023 | 4.028M |
| June 30, 2023 | 4.052M |
| March 31, 2023 | 4.052M |
| December 31, 2022 | 3.047M |
| September 30, 2022 | -0.339M |
| June 30, 2022 | -0.363M |
| March 31, 2022 | -0.339M |
| Date | Value |
|---|---|
| December 31, 2021 | -0.339M |
| September 30, 2021 | -0.137M |
| June 30, 2021 | -0.136M |
| March 31, 2021 | -0.161M |
| December 31, 2020 | -0.162M |
| September 30, 2020 | -0.165M |
| June 30, 2020 | -0.202M |
| March 31, 2020 | -0.218M |
| December 31, 2019 | -0.236M |
| September 30, 2019 | -0.143M |
| June 30, 2019 | -0.083M |
| March 31, 2019 | -0.042M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| InMed Pharmaceuticals, Inc. | -0.1222M |
| NervGen Pharma Corp. | -0.0404M |
| Appili Therapeutics, Inc. | 0.2695M |
| Clearmind Medicine, Inc. | -0.0543M |
| Lexaria Bioscience Corp. | 0.095M |